A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT Number: NCT04172155
the aim of this study is to evaluate the evolution of self-esteem during a pulmonary rehabilitation program, in COPD patients.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
CHRU de Brest, Brest, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: PSI-6 is measured at the biginning and at the end of the pulmonary rehabilitation program (4 weeks)
the physical self inventory- 6 (PSI-6) allows to evaluate self esteem
Time frame: the 6MWT is measured at the biginning and at the end of the pulmonary rehabilitation program (4 weeks)
The 6-minute walk test allows to evaluate exercise capacity
Time frame: HAD is measured at the biginning and at the end of the pulmonary rehabilitation program (4 weeks)
the hospital anxiety and depressive scale (HAD) measure the anxiety and depression
Time frame: SGRQ is measured at the biginning and at the end of the pulmonary rehabilitation program (4 weeks)
the Saint-George respiratory Questionnaire (SGRQ) measure the quality of life
Time frame: MMRC is measured at the biginning and at the end of the pulmonary rehabilitation program (4 weeks)
The modified medical research Council dyspnea scale measure dyspnea
University Hospital, Brest
Other
Effects of Pulmonary Rehabilitation on Self-esteem in Patients With COPD
Acronym: ESMOI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details